Avidity Biosciences Inc
(RNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||
| Net Income | -22,050 | -16,490 | -10,650 |
| Depreciation Amortization | 1,590 | 1,210 | 790 |
| Other Working Capital | -11,150 | -1,770 | -3,860 |
| Other Operating Activity | 2,430 | -5,850 | 510 |
| Operating Cash Flow | $-29,180 | $-22,900 | $-13,210 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -800 | -560 | -450 |
| Other Investing Activity | 240 | -50 | -50 |
| Investing Cash Flow | $-560 | $-610 | $-500 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 84,840 | 84,380 | 700 |
| Financing Cash Flow | $84,840 | $84,380 | $700 |
| Exchange Rate Effect | 10 | 30 | -30 |
| Beginning Cash Position | 54,110 | 53,960 | 53,190 |
| End Cash Position | 109,220 | 114,870 | 40,160 |
| Net Cash Flow | $55,110 | $60,900 | $-13,030 |
| Free Cash Flow | |||
| Operating Cash Flow | -29,180 | -22,900 | -13,210 |
| Free Cash Flow | -29,180 | -22,900 | -13,210 |